Immunotherapy for Metastatic Kidney Cancer Shows Increased Survival
2 Tampilan
• 07/10/23
0
0
Menanamkan
administrator
Pelanggan
The immune checkpoint inhibitor Opdivo (nivolumab) has been shown to increase survival for patients with metastatic clear cell kidney cancer (also called renal cell carcinoma, or RCC).
Menampilkan lebih banyak
Komentar Facebook
SORT BY-
Komentar Teratas
-
komentar terbaru